Worley Nancy, Buza John, Jalai Cyrus M, Poorman Gregory W, Day Louis M, Vira Shaleen, McClelland Shearwood, Lafage Virginie, Passias Peter G
Division of Spine Surgery, New York University Hospital for Joint Diseases, New York, NY.
Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY.
Int J Spine Surg. 2017 Apr 3;11(2):10. doi: 10.14444/4010. eCollection 2017.
Diabetes as an independent driver of peri-operative outcomes, and whether its severity impacts indications is conflicted in the research. The purpose of this study is to evaluate diabetes as a predictor for postoperative outcomes in cervical spondylotic myelopathy (CSM) patients.
A retrospective review was performed of patients treated surgically for CSM (ICD-9 721.1) from 2010-2012 in the prospectively-collected American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database. Outcome measures were length of stay, and the presence of complications. Diabetic patients were stratified based on whether or not their diabetes was insulin- or non-insulin-dependent.
A total of 5,904 surgical CSM patients were included, 1101 (19%) had diabetes. 722 (65%) were non-insulin-dependent diabetics, and 381 (35%) were insulin-dependent diabetics. Diabetes was found to be an independent predictor of extended LOS (OR: 1.878[2.262-1.559], p<0.001) as well as of developing a complication (OR: 1.666[2.217-1.253], p<0.001) after controlling for associated variables like BMI. Type of diabetes (insulin- vs. non-insulin-dependent) showed little significant difference between the groups (p>0.05), however, patients with insulin-dependent diabetes were associated with an increased incidence of wound complications (p=0.027); severity of diabetes was not associated with any other individual complications.
Type and severity of diabetes is not a predictor for complication. Diabetes is associated with extended LOS and peri-operative morbidity. Level of evidence: Class 2b. Clinical relevance: Our findings support the view of many spine surgeons, who believe that diabetes has a negative impact on the outcome of surgery for CSM. Our findings support those cohort studies that found an association between diabetes and worst post-operative outcomes following surgical treatment of CSM. These findings lend support to the importance of monitoring preoperative serum glucose levels, as prevention of peri-operative hyperglycemia has been linked to improved postoperative outcomes in spine, joint and colon surgery.
糖尿病作为围手术期结局的独立驱动因素,以及其严重程度是否影响手术指征,在研究中存在争议。本研究的目的是评估糖尿病作为脊髓型颈椎病(CSM)患者术后结局的预测因素。
对2010年至2012年在美国外科医师学会国家外科质量改进计划(NSQIP)前瞻性收集的数据库中接受CSM手术治疗(ICD-9 721.1)的患者进行回顾性分析。结局指标为住院时间和并发症的发生情况。糖尿病患者根据其糖尿病是否依赖胰岛素进行分层。
共纳入5904例接受CSM手术的患者,其中1101例(19%)患有糖尿病。722例(65%)为非胰岛素依赖型糖尿病患者,381例(35%)为胰岛素依赖型糖尿病患者。在控制了如BMI等相关变量后,发现糖尿病是延长住院时间的独立预测因素(OR:1.878[2.262-1.559],p<0.001)以及发生并发症的独立预测因素(OR:1.666[2.2